Company Overview
Snapshot
Founded in March 2008 by Shaul Gelman, Carmel Rotschild, and Aviad Kaufman, RealView Imaging operates with 11–50 employees. The company has raised a total of $36.5M across 6 funding rounds from 7 investors. In March 2023, RealView Imaging secured convertible debt funding, with OurCrowd participating as a lead investor.
Business overview
RealView Imaging specializes in interactive live holography, developing proprietary Digital Light Shaping technology to create accurate three-dimensional holograms for medical imaging. The company's core product, the HOLOSCOPE-i system, provides physicians with a natural 3D visualization experience without the need for head-mounted devices or special eyewear. RealView Imaging targets the high-end 3D medical imaging market, particularly for interventional cardiology procedures, and operates within the Digital Healthcare and Medical Decision Support sectors.
Strategic signal
In November 2021, RealView Imaging received FDA 510(k) clearance for its Holoscope-i holographic system, which creates spatially accurate, three-dimensional interactive medical holograms. This regulatory approval is a significant validation of the company's technology and its potential for commercialization in North America, signaling a clear path for market expansion and adoption within the medical community.
Log in to access full profile ›Company Intelligence Q&A
- What was a significant recent funding event for RealView Imaging?
- In March 2023, RealView Imaging secured convertible debt funding, with OurCrowd participating as a lead investor.
- What was a key regulatory milestone for RealView Imaging's Holoscope-i system?
- In November 2021, RealView Imaging received FDA 510(k) clearance for its Holoscope-i holographic system, which generates spatially accurate, three-dimensional interactive medical holograms.
- Which investors participated in RealView Imaging's August 2021 funding round?
- In August 2021, RealView Imaging received funding from Club 100 Plus and Dr. Shimon Eckhouse, among others, as part of an extension to its Series C financing round.
- When did RealView Imaging complete its Series C funding round?
- In July 2020, RealView Imaging completed a Series C financing round, with new investors including OurCrowd and Judith.
- When was RealView Imaging's holographic imaging technology first used in a live medical procedure?
- In April 2019, cardiologists and cardiac surgeons at Toronto General Hospital’s Peter Munk Cardiac Centre performed the first live medical procedure using RealView Imaging's real-time holographic imaging technology, the HOLOSCOPE-i system.